Vaccine

National Immunization Awareness Month: Your daily diet plays a crucial role in maintaining the body's ability to ward off diseases. Certain foods with rich nutrients can actually increase your overall body response, helping to produce antibodies that will last longer to protect you from the disease.

Biological E partners with China’s Recbio to manufacture HPV9 vaccine for India, global markets

Under the terms of the deal, Recbio will transfer the technology and supply the drug substance (DS) to BE, enabling the Indian firm to formulate, fill, and package the vaccine.

COVID Cases Rising In India: All You Need To Know

India is witnessing a rise in COVID-19 cases, with active infections surpassing 1,000 as of May 26, up sharply from 257 the previous week. Seven deaths were reported in the past week. Most cases are mild and do not require hospitalisation. The surge is driven by two new Omicron sub-variants, LF.7 and NB.1.8, while the JN.1 strain remains dominant. These new variants are classified by WHO as "Variants Under Monitoring," indicating ongoing observation but no immediate cause for concern. Symptoms are similar to flu and earlier Omicron strains, including sore throat, fatigue, mild cough, and fever, with most patients recovering at home. The rise is concentrated in states like Kerala, Maharashtra, Delhi, Tamil Nadu, and Karnataka. India’s extensive vaccination campaign, with over 2.2 billion doses administered, continues to be crucial in preventing severe illness, hospitalisation, and death. Health authorities urge eligible individuals to complete vaccinations and boosters to mitigate the impact of the current mild surge.

Serum Institute of India to make mpox vaccine for Denmark's Bavarian Nordic

Bavarian will transfer the technology to Serum Institute to supply the shots for Indian market. Serum Institute will also carry out contract manufacturing on profit-sharing model for Bavarian Nordic to help expand global capacity.

The UN authorizes the 1st mpox vaccine for children in an attempt to control the outbreak in Congo

In a statement late Tuesday, the UN health agency said it had approved the mpox vaccine made by Japanese company KM Biologics for use in children over 1 year of age as a single dose.

Polio vaccine myths Vs facts: Does it cause paralysis? Is it safe for children?

There are many myths regarding the polio vaccine in India. This factual guide will help you clear common misconceptions regarding the vaccine and understand why immunisation is important for your overall well-being.

H9N2 avian flu symptoms, cure: How to keep your child safe from bird flu

H9N2 bird flu prevention, management, and treatment depend on an understanding of how children are affected differently from adults. Children's developing immune systems and distinct physiological traits put them at risk of serious problems, even though they may have lesser symptoms.

Top vaccine maker Serum Institute sees demand doubling in five years

The world’s largest vaccine maker currently has the capacity to produce 3 billion doses of all types of vaccines each year, but only sells about 1.5 billion doses annually. The Pune-based firm is forecasting that will change.

Vaccination myths vs facts: Delaying or skipping vaccine schedule can leave children vulnerable to diseases

Timely vaccination plays a crucial role in cutting hospital stays and preventing the spread of infectious diseases. Vaccines work most effectively when administered according to the recommended schedule, providing children with optimal protection from vaccine-preventable diseases.

Serum Institute eyes approval for XBB1 variant vaccine to tackle COVID-19 JN.1 strain

India reported 1,394 active cases of Covid-19 on December22, 5 am, according to the data provided by the Ministry of Health and Family Welfare

PM Modi praises 'The Vaccine War': Every Indian is feeling proud after watching film

The Vivek Agnihotri-directed movie, which released theatrically on September 28, is based on the true story of Indian scientists, their fight against the COVID-19 pandemic and how they developed an affordable vaccine for India and the world.

US CDC backs Pfizer's maternal RSV vaccine to protect infants

The CDC recommendation comes after a panel of advisers voted 11 to 1 for use of the shot in women 32 weeks to 36 weeks into their pregnancy from September to January, paving the way for it to become the first maternal vaccine for the seasonal respiratory virus available in the country.

India's Nipah virus trackers gather samples from bats, fruit

The state is battling its fourth outbreak since 2018 of a virus for which there is no vaccine, and which spreads through contact with the body fluids of infected bats, pigs or people, killing up to 75% of those infected.

WHO classifies 'Eris' Covid strain as 'variant of interest’

The WHO and its Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) continue to regularly assess the impact of variants on the performance of COVID-19 vaccines to inform decisions on updates to vaccine composition.

India records 49 new Covid infections, count of active cases now 1,463

The national COVID-19 recovery rate is at 98.81 per cent and the number of people who have recuperated from the disease has surged to 4,44,61,168, the data showed.

The Great Grift: More than $200 billion in COVID-19 aid may have been stolen, federal watchdog says

The numbers issued on Tuesday by the US Small Business Administration inspector general are much greater than the office's previous projections and underscore how vulnerable the Paycheck Protection and COVID-19 Economic Injury Disaster Loan programmes were to fraudsters, particularly during the early stages of the coronavirus pandemic.

Gennova's mRNA jab gets regulator nod, 1.2 million boosters approved by CDL Kasauli

The Department of Biotechnology (DBT) on June 20 announced that the Omicron-specific mRNA-based booster vaccine developed using the indigenous platform technology by Gennova was supported under the Mission Covid Suraksha.

Exclusive: ICMR reviewing preliminary findings on link between Covid jabs and sudden heart attack deaths: DG Rajiv Bahl

Bahl said the institute was conducting four studies to assess the link between COVID vaccination and sudden heart attack deaths in India. One study focuses on assessing the sudden heart attack deaths from the angles of vaccination, long COVID, and severity of the patient’s condition, the ICMR chief said.

Bharat Biotech recalls batch of typhoid vaccine after CDSCO red flag

The TYPBAR vaccine was first in India to get a World Health Organisation Good Manufacturing Practice (WHO-GMP) prequalification certificate

G7 plans new vaccine program for developing nations

In addition to the G7, G20 nations such as India and international groups such as the World Health Organization (WHO) and the World Bank will participate, it added, citing Japanese government sources.

COVID-19 vaccine maker Novavax to chop workforce, expenses

The company had 1,992 full-time employees as of February 21, according to Securities and Exchange Commission filings.

Oxford University, Serum Institute of India tie-up delivers ‘high efficacy’ malaria vaccine

The R21/Matrix-M vaccine, leveraging Novavax's adjuvant technology, has been approved for use by Africa's Food and Drugs Authority in Ghana for children aged 5 to 36 months - the age group at the highest risk of death from malaria.

Serum Institute of India restarts manufacturing of COVID-19 vaccine Covishield

He said the company already has six million booster doses of Covovax vaccine available and adults must take the booster shot.

Serum Institute seeks inclusion of Covovax on CoWIN as heterologous booster dose for adults

The letter was written by Prakash Kumar Singh, Director, Serum Institute of India (SII) on March 27, they said.

COVID-19: WHO revises its vaccine advisory — All You Need to Know

The WHO in its latest Strategic Advisory Group of Experts on Immunization (SAGE) has revised the roadmap for prioritising use of COVID-19 vaccines. Here’s all you need to know